A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)
Clinical trial NCT01565148 · TERMINATED
Trial details
- NCT number
- NCT01565148
- Sponsor
- Johns Hopkins University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-02-01
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.